Home Biosimilar Antibodies Immunology & Inflammation Interleukins antibody Lebrikizumab (Anti-IL-13) For research use only.
Not for use in humans.

Lebrikizumab (Anti-IL-13)

Synonyms:

Lebrikizumab (anti-IL-13) is an humanized IgG4 monoclonal antibody against interleukin 13 (IL-13) with immunosuppressive and anti-asthmatic activities. MW: 145.8 KD.

Lebrikizumab (Anti-IL-13)

Purity & Quality Control

≥99

Choose Selective Interleukins Inhibitors

Biological Activity

Description Lebrikizumab (anti-IL-13) is an humanized IgG4 monoclonal antibody against interleukin 13 (IL-13) with immunosuppressive and anti-asthmatic activities. MW: 145.8 KD.

Product Details

CAS No. 953400-68-5
Molecular Weight 145.28
Isotype Human IgG4SP
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Lebrikizumab (Anti-IL-13) | Lebrikizumab (Anti-IL-13) supplier | purchase Lebrikizumab (Anti-IL-13) | Lebrikizumab (Anti-IL-13) cost | Lebrikizumab (Anti-IL-13) manufacturer | order Lebrikizumab (Anti-IL-13) | Lebrikizumab (Anti-IL-13) distributor